Sign in
Taking peopleNo phase

Factors linked to symptoms in people with Wilson disease over long-term follow-up

Follows people with Wilson disease to find factors linked to their symptoms.

Key facts

Who runs it
Second Affiliated Hospital, Zhejiang University, School of Medicine
Where
China1 site in 1 countryChoose a country to see its sites
Trial code
Registry title
Role for Biochemical Assays and Kayser-Fleischer Rings in Diagnosis of Wilson Disease
Status
Recruiting
People taking part
1,000 people, planned
Started
1 Jan 2004
Expected to end
1 Jan 2030
Type of study
Observational
Treatments tested
  • low copper diet
Record updated
16 July 2021

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for people with Wilson disease confirmed by a genetic test. It follows them over a long time to study their symptoms.

Age
6 Years to 65 Years
Sex
All sexes can join
Disease stage
Wilson disease diagnosed by a genetic test
Biomarker or test result
Disease-causing changes in the ATP7B gene on 2 different copies of the gene

Main reasons for not taking part

  • People who refuse follow-up visits cannot join

The registry criteria, word for word

Show all 2 criteriaShow less

Who can take part

  • genetically diagnosed patients with wilson disease

Who cannot take part

  • Deny follow-up

The main criteria, as questions

These questions come from the eligibility criteria published for this trial. They help you read the criteria and prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.

  • Are you between 6 and 65 years old?

This trial is currently available in China.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

The investigators aimed to identify factors associated with symptoms and features of Wilson disease from a large cohort during long-term follow-up

The group in the trial

  • Wilson's disease cohort

    Patients were clinically diagnosed according to the Leipzig Score and included in the study when they were confirmed to carry ATP7B pathogenic variants in 2 different alleles.

    Treatment: low copper diet

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Role for Biochemical Assays and Kayser-Fleischer Rings in Diagnosis of Wilson Disease
Plain-language title
Factors linked to symptoms in people with Wilson disease over long-term follow-upGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 15 November 2026.
Criteria questions
Built from NCT04965545, who can take part
Record updated
16 July 2021